|
Actu-presse
Publications: 2004
Equipe
1
Defoort-Dhellemmes
S, Lebrun T, Arndt CF, Bouvet-Drumare I, Guilbert
F, Puech B, Hache JC (2004). [Congenital achromatopsia:
electroretinogram in early diagnosis]. J Fr
Ophtalmol,27:143-148.
Hanein
S, Perrault I, Gerber S, Tanguy G, Barbet F, Ducroq D,
Calvas P, Dollfus H, Hamel C, Lopponen T, Munier
F, Santos L, Shalev S, Zafeiriou D, Dufier JL, Munnich
A, Rozet JM, Kaplan J (2004). Leber congenital amaurosis:
comprehensive survey of the genetic heterogeneity, refinement
of the clinical definition, and genotype-phenotype correlations
as a strategy for molecular diagnosis. Hum
Mutat,23:306-317.
Lorenz
B, Wabbels B, Wegscheider E, Hamel CP, Drexler W,
Preising MN (2004). Lack
of fundus autofluorescence to 488 nanometers from childhood
on in patients with early-onset severe retinal dystrophy
associated with mutations in RPE65. Ophthalmology,111:1585-1594.
Nicot
A, Otto T, Brabet P, DiCicco-Bloom EM (2004). Altered
social behavior in pituitary adenylate cyclase-activating
polypeptide (PACAP) type I receptor deficient mice. J Neuroscience 24,
8786-8795.
Payet
O,
D’Aldin C, Maurin L, Bonne C, Muller A (2004).
Anti-excitotoxic activity of trimetazidine in the retina. J
Ocular Pharmacol Ther 20,
85-92.
Payet
O,
Maurin L, Bonne C, Muller A (2004). Hypoxia
stimulates glutamate uptake in whole rat retinal cells
in vitro. Neurosci Lett 356,
148-150.
Perrault
I, Hanein S, Gerber S, Barbet F, Ducroq D, Dollfus H, Hamel
C, Dufier JL, Munnich A, Kaplan J, Rozet JM (2004). Retinal
Dehydrogenase 12 (RDH12) Mutations in Leber Congenital
Amaurosis. Am J Hum Genet,75:639-646.
Reynier
P, Amati-Bonneau P, Verny C, Olichon A, Simard G, Guichet
A, Bonnemains C, Malecaze F, Malinge MC, Pelletier JB,
Calvas P, Dollfus H, Belenguer P, Malthiery Y, Lenaers
G, Bonneau D (2004). OPA3
gene mutations responsible for autosomal dominant optic
atrophy and cataract. J Med Genet,41:e110.
Wang
J, Ladrech S, Pujol R, Brabet P, Van De Water TR,
Puel JL (2004). Caspase
inhibitors, but not c-Jun NH2-terminal kinase inhibitor
treatment, prevent cisplatin-induced hearing loss. Cancer
Res 64, 9217-9224.
Equipe
2
Boyer
S, Ruel J, Puel JL, Chabbert C (2004) A procedure
to label inner ear afferent nerve endings for calcium imaging. Brain
Res Brain Res Protoc,13:91-98.
Duan
M, Venail F, Spencer N, Mezzina M. Treatment
of peripheral sensorineural hearing loss: gene therapy. Gene
Ther. 2004 Oct;11 Suppl 1:S51-6.
Eybalin
M,
Caicedo A, Renard N, Ruel J, Puel JL.
Transient Ca2+-permeable AMPA receptors in postnatal
rat primary auditory neurons. Eur
J Neurosci. 2004
Dec;20(11):2981-9.
Guitton
MJ, Avan P, Puel JL, Bonfils P (2004) Medial olivocochlear
efferent activity in awake guinea pigs. Neuroreport,15:1379-1382.
Guitton
MJ, Wang J, Puel JL (2004) New pharmacological
strategies to restore hearing and treat tinnitus. Acta
Otolaryngol,124:411-415.
Ladrech
S,
Guitton M, Saido S, Lenoir M (2004) Calpain activity
in the amikacin damaged rat cochlea. J Comp
Neurol,477:149-160.
Nicolas
MT, Lesage F, Reyes R, Barhanin J, Dememes D (2004)
Localization of TREK-1, a two-pore-domain K(+) channel
in the peripheral vestibular system of mouse and rat. Brain
Res,1017:46-52.
Roux
AF, Pallares-Ruiz N, Vielle A, Faugere V, Templin C, Leprevost
D, Artieres F, Lina G, Molinari N, Blanchet P, Mondain
M, Claustres M (2004) Molecular epidemiology of DFNB1
deafness in France. BMC Genet,5:5.
Roza
C, Puel JL, Kress M, Baron A, Diochot S (2004) Knockout
of the ASIC2 channel does not impair cutaneous mechanosensation,
visceral mechanociception and hearing. J Physiol 2004
Jul 15;558(Pt 2):659-69.
Thai-Van
H, Truy E, Charasse B, Boutitie F, Chanal JM, Cochard
N, Piron JP, Ribas S, Deguine O, Fraysse B, Mondain
M, Uziel A, Collet L. Modeling
the relationship between psychophysical perception and
electrically evoked compound action potential threshold
in young cochlear implant recipients: clinical implications
for implant fitting. Clin Neurophysiol. 2004
Dec;115(12):2811-24.
Venail
F,
Roux AF, Pallares-Ruiz N, Claustres M, Blanchet P, Gardiner
Q, Mondain M (2004) Nonsyndromic 35 delG mutation
of the connexin 26 gene associated with deafness in syndromic
children: two case reports. Laryngoscope,114:566-569.
Venail
F, Gardiner Q, Mondain M. ENT
and speech disorders in children with Down's syndrome:
an overview of pathophysiology, clinical features, treatments,
and current management. Clin Pediatr (Phila).
2004 Nov-Dec;43(9):783-91.
Wang
J, Ladrech
S, Pujol R, Brabet P, Van de Water TR, Puel
J-L (2004). Caspase
Inhibitors, but not c-Jun N-Terminal Kinase Inhibitor
Treatment Prevent Cisplatin-Induced Hearing Loss. Cancer
Res 64,
9217-9224.
Zine
A (2004)
[Stem cells to repair neurosensory deafness?]. Med
Sci (Paris),20:518-520.
Zine
A, van de Water TR. The
MAPK/JNK signalling pathway offers potential therapeutic
targets for the prevention of acquired deafness. Curr
Drug Targets CNS Neurol Disord. 2004 Aug;3(4):325-32.
Equipe
3
Chanut-Delalande
H, Bonod-Bidaud C, Cogne S, Malbouyres M, Ramirez F, Fichard
A, Ruggiero F (2004) Development of a functional skin
matrix requires deposition of collagen V heterotrimers. Mol
Cell Biol,24:6049-6057.
Coubes
P, Cif L, El Fertit H, Hemm S, Vayssiere N, Serrat S, Picot
MC, Tuffery S, Claustres M, Echenne B, Frerebeau
P (2004) Electrical stimulation of the globus pallidus
internus in patients with primary generalized dystonia:
long-term results. J Neurosurg,101:189-194.
Demir
E, Ferreiro A, Sabatelli P, Allamand V, Makri S, Echenne
B, Maraldi M, Merlini L, Topaloglu H, Guicheney P (2004)
Collagen VI status and clinical severity in Ullrich congenital
muscular dystrophy: phenotype analysis of 11 families linked
to the COL6 loci. Neuropediatrics,35:103-112.
Dubreuil
AS, Boukhaddaoui H, Desmadryl G, Martinez-Salgado C, Moshourab
R, Lewin GR, Carroll P, Valmier J, Scamps
F (2004). Role of T-type calcium currunet in identified
D-hair mechanoreceptor neurons studied in vitro. J
Neurosci 24, 8480-8484.
Echenne
B,
Rivier F, Roubertie A, Carson NL (2004) Congenital
club foot with survival of motor neuron 1, telomeric
(SMN1) gene deletion. J Child Neurol,19:212-213.
Kozlenkov
A, Le Du MH, Cuniasse P, Ny T, Hoylaerts MF, Millán
JL. Residues
determining the binding specificity of uncompetitive
inhibitors to tissue-nonspecific alkaline phosphatase. J
Bone Miner Res. 2004 Nov;19(11):1862-72.
Mikaeloff
Y, Rey E, Soufflet C, d'Athis P, Echenne B, Vallée
L, Bouhours P, Grinspan A, Dulac O, Pons G, Chiron C. Topiramate
pharmacokinetics in children with epilepsy aged from
6 months to 4 years. Epilepsia.
2004 Nov;45(11):1448-52.
Nal
B, Carroll P, Mohr E, Verthuy C, Da Silva MI, Gayet
O, Guo XJ, He HT, Alcover A, Ferrier P (2004) Coronin-1
expression in T lymphocytes: insights into protein function
during T cell development and activation. Int
Immunol,16:231-240.
Roubertie
A,
Leydet J, Rivier F, Humbertclaude V, Cheminal R, Echenne
B (2004) [Movement disorders in childhood: therapeutic
update]. Arch Pediatr,11:951-954.
Rousset
M, Cens T, Gouin-Charnet A, Scamps F, Charnet P
(2004) Ca2+ and phosphatidylinositol 4,5-bisphosphate stabilize
a Gbeta gamma-sensitive state of Ca V2 Ca 2+ channels. J
Biol Chem,279:14619-14630.
Sabatier
N, Shibuya I, Dayanithi G (2004) Intracellular calcium
increase and somatodendritic vasopressin release by vasopressin
receptor agonists in the rat supraoptic nucleus: involvement
of multiple intracellular transduction signals. J
Neuroendocrinol,16:221-236.
Scamps
F,
Roig A, Boukhaddaoui H, Andre S, Puech S, Valmier
J (2004) Activation of P-type calcium channel regulates
a unique thapsigargin-sensitive calcium pool in embryonic
motoneurons. Eur J Neurosci,19:977-982.
Shibuya
I, Dayanithi G, Ueta Y (2004) Stimulus-secretion
coupling. Naibunpitsu tounyouka. Endocrinol
and Diabetol,18:403-410.
Tuffery-Giraud
S, Saquet C, Chambert S, Echenne B, Marie Cuisset
J, Rivier F, Cossee M, Philippe C, Monnier N, Bieth E,
Recan D, Antoinette Voelckel M, Perelman S, Lambert JC,
Malcolm S, Claustres M (2004) The role of muscle biopsy
in analysis of the dystrophin gene in Duchenne muscular
dystrophy: experience of a national referral centre. Neuromuscul
Disord,14:650-658.
Watson
R, Jiang Y, Bermudez I, Houlihan L, Clover L, McKnight
K, Cross JH, Hart IK, Roubertie A, Valmier J, Hart
Y, Palace J, Beeson D, Vincent A, Lang B (2004) Absence
of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen
encephalitis. Neurology,63:43-50.
Equipe
4
Bonny
JM, Gaviria M, Donnat JP, Jean B, Privat A, Renou
JP (2004) Nuclear magnetic resonance microimaging of mouse
spinal cord in vivo. Neurobiol Dis,15:474-482.
Cambonie
G, Hirbec H, Michaud M, Kamenka JM, Barbanel G (2004)
Prenatal infection obliterates glutamate-related protection
against free hydroxyl radicals in neonatal rat brain. J
Neurosci Res,75:125-132.
Chauvet
N, Privat
A, Prieto M (2004) Differential expression of p120
catenin in glial cells of the adult rat brain. J
Comp Neurol,479:15-29.
Goumon
Y, Angelone T, Schoentgen F, Chasserot-Golaz S, Almas B,
Fukami MM, Langley K, Welters ID, Tota B, Aunis
D, Metz-Boutigue MH (2004) The hippocampal cholinergic
neurostimulating peptide, the N-terminal fragment of the
secreted phosphatidylethanolamine-binding protein, possesses
a new biological activity on cardiac physiology. J
Biol Chem,279:13054-13064.
Jouvert
P, Revel MO, Lazaris D, Aunis D, Langley K, Zwiller
J (2004) Activation of the cyclic GMP pathway in dopaminergic
structures reduces cocaine-induced EGR-1 expression and
locomotor activity. J Neurosci 2004
Nov 24;24(47):10716-25.
Lopez
S, Privat A, Bernard N, Ohanna F, Vergnes C, Capdevila
X (2004) Intrathecal bupivacaine protects against extension
of lesions in an acute photochemical spinal cord injury
model. Can J Anaesth,51:364-372.
Mausset-Bonnefont
AL, Hirbec H, Bonnefont X, Privat A, Vignon J, de Sèze
R. Acute
exposure to GSM 900-MHz electromagnetic fields induces
glial reactivity and biochemical modifications in the
rat brain. Neurobiol Dis. 2004
Dec;17(3):445-54.
Ribotta
MG, Menet V, Privat A. Glial
scar and axonal regeneration in the CNS: lessons from
GFAP and vimentin transgenic mice. Acta Neurochir
Suppl. 2004;89:87-92.
Sarlieve
LL, Rodriguez-Pena A, Langley K (2004) Expression
of thyroid hormone receptor isoforms in the oligodendrocyte
lineage. Neurochem
Res,29:903-922.
Equipe
5
Boyer
S, Ruel J, Puel JL, Chabbert C (2004) A procedure
to label inner ear afferent nerve endings for calcium imaging. Brain
Res Brain Res Protoc,13:91-98.
Dubreuil
AS, Boukhaddaoui H, Desmadryl G, Martinez-Salgado
C, Moshourab R, Lewin GR, Carroll P, Valmier J, Scamps
F (2004). Role of T-type calcium currunet in identified
D-hair mechanoreceptor neurons studied in vitro. J
Neurosci 24, 8480-8484.
Haut de la page
|
